B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Decernotinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Decernotinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

baricitinib
17 shared targets
y
13 shared targets
tofacitinib
15 shared targets
momelotinib
16 shared targets
zotiraciclib
16 shared targets
ucn
18 shared targets
sar
8 shared targets
ripasudil
9 shared targets
pacritinib
13 shared targets
filgotinib
9 shared targets
Loading evidence profile...

This evidence profile for Decernotinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.